Literature DB >> 8792343

Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity.

J A Cook1, D A Wink, V Blount, M C Krishna, I Hanbauer.   

Abstract

Under aerobic conditions the addition of (C2N5)2N(N[O]NO)-.Na+(DEA/NO), S-nitroso-N-acetyl penicillamine and nitric oxide (NO)-saturated buffer, but not S-nitroso-L-glutathione, to dopamine solutions resulted in dopamine o-semiquinone formation that was dependent on the formation of a NO/oxygen intermediate. High pressure liquid chromatography (HPLC) electrochemical analysis of dopamine demonstrated that the DEA/NO-induced oxidation of dopamine was abrogated in the presence of the antioxidants, ascorbate and glutathione. NO spontaneously released from DEA/NO decreased [3H]dopamine accumulation in primary cultures of mesencephalic neurons in a dose-dependent fashion. In contrast, [3H] gamma-aminobutyric acid uptake by mesencephalic neurons tested under the same conditions was unchanged. When DEA/NO was added to incubation buffer that contained [3H]dopamine and the antioxidant, ascorbate or glutathione, [3H]dopamine uptake was also inhibited. These data excluded that oxidation of extracellular [3H]dopamine by the intermediates of the NO/O2 reaction could have caused this decrease. Instead, NO may have acted directly on a not yet identified target operative in the regulation of dopamine storage and release. Analysis of the rate constants for the NO reaction with ascorbate, glutathione and dopamine revealed that dopamine quinone formation was delayed by the presence of antioxidants. Since the formation of NO as well as neurotransmitter release are activated during ischemia reperfusion injury, it is possible that prolonged NO exposure could deplete antioxidants and facilitate the oxidation of dopamine and thereby cause neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792343     DOI: 10.1016/0197-0186(95)00125-5

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

1.  Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter.

Authors:  Bo-Jin Cao; Maarten E A Reith
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  The biochemical basis of synaptic plasticity and neurocomputation: a new theory.

Authors:  J Smythies
Journal:  Proc Biol Sci       Date:  1997-04-22       Impact factor: 5.349

3.  The role of adrenochrome in stimulating the oxidation of catecholamines.

Authors:  A Bindoli; G Scutari; M P Rigobello
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

4.  Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.

Authors:  D Metodiewa; C Kośka
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

5.  Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).

Authors:  Lesley J Bryan-Lluka; Marisa H Papacostas; Filip A Paczkowski; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

Review 6.  Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity.

Authors:  Thiago Fernando Beckhauser; José Francis-Oliveira; Roberto De Pasquale
Journal:  J Exp Neurosci       Date:  2016-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.